Management of Primary-Open Angle Glaucoma *ACPE-Accredited*

On this episode, we review the pharmacotherapy options available for managing primary-open angle glaucoma. We discuss prostaglandin analogs, beta-blockers, alpha-2 agonists, carbonic anhydrase inhibitors, cholinergics, rho kinase inhibitor, and more. We also briefly review angle-closure glaucoma to finish the episode.

Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website:

https://www.freece.com/

If you’re not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast.

Thanks for listening!

We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial:

www.pyrls.com/corconsultrx

If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below:

www.patreon.com/corconsultrx

If you have any questions for Cole or me, reach out to us on any of the following:

Text - 415-943-6116

• Mike - [email protected]
• Cole - [email protected]
• AJ - [email protected]

Instagram and other social media platforms - @corconsultrx

This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.